EDUCATION
|
Grand Medical College, University of Bombay |
M.B.B.S. |
1971 |
Medicine |
|
University of Bombay |
M.D. |
1979 |
Pediatrics |
PROFESSIONAL EXPERIENCE
| 1978-1979 |
Instructor in Pediatrics, New York Medical
College, New York, NY |
| 1978-1979 |
Attending in Pediatrics, Flower Fifth Avenue
Hospital, New York, NY |
| 1979-1980 |
Attending in Pediatrics, Metropolitan Hospital
Center, New York, NY |
| 1979-1990 |
Assistant Professor of Pediatrics, New York
Medical College, New York, NY |
| 1980-1985 |
Director of Pediatric Outpatient Department,
Metropolitan Hospital Center, New York, NY |
| 1985-1986 |
Director of Inpatient Services, Lincoln Hospital
Center, New York, NY |
| 1986-1990 |
Associate Chief of Pediatrics, Metropolitan
Hospital Center, New York, NY |
| 1986-present |
Director of Pediatric Intensive Care Unit,
Metropolitan Hospital Center, New York, NY |
| 1986-present |
Director of Pediatric AIDS, Metropolitan
Hospital Center, New York, NY |
| 1990-2000 |
Associate Professor of Clinical Pediatrics, New
York Medical College, New York, NY |
| 1990-present |
Deputy Chief of Pediatrics, Metropolitan
Hospital Center, New York, NY |
| 2000-present |
Professor of Clinical Pediatrics, New York
Medical College, New York, NY |
PUBLICATIONS
Bamji, M., The NICHD Intravenous Immunoglobulin Study Group: Efficacy of
intravenous immunoglobulin for the prophylaxis of serious bacterial infection in
symptomatic human immunodeficiency virus infected children. New England Journal
of Medicine, 325: 73-80, 1991.
Bamji, M., The National Institute of Child Health and Human Development
Intravenous Immunoglobulin Study Group: Intravenous immune gamma globulin for
the prevention of bacterial infections in children with symptomatic human
immunodeficiency virus infection. New England Journal of Medicine, 325: 75-80,
1991.
Don, P.C., Shen, N.N., Sierra, M.F., Stone, R.K., Bamji, M., Department of
Dermatology and Pediatrics-NYMC and Department of Pathology: Fungal colonization
in HIV-positive children. Clinical Research, 39(3), 1991.
Parekh, S.B., Shaffer, N., Pau, C.P., Abrams, E., Thomas, P., Pollack, H., Bamji,
M., Kaul, A., Schochetman, G., Rogers, M., George, J.R., and the NYC Perinatal
Transmission Collaborative Study: Lack of correlation between maternal
antibodies to V3 Loop peptides of gp120 and perinatal HIV-1 transmission. AIDS,
5:1184-1197, 1991.
Kaplan, E.J., Abrams, E., Shaffer, N., Cannon, R.O., Kaul, A., Krasinski, K.,
Bamji, M., Hartley, T.M., Roberts, B., Kilbourne, B., Thomas, P., Rogers, M.,
Heneine, W.: Lack of mother-to-child transmission of human T-lymphotropic virus
type II (HTLV-II) in non-breast fed infants. Journal of Infectious Diseases,
166:892-5, 1992.
Mofenson, L.M., Moye, J., Hirschhorn, R., Jordan, C., Nugent R for the National
Institute of Child Health and Human Development Intravenous Immunoglobulin
Clinical Trial Study Group, Bamji, M.: Efficacy of intravenous immunoglobulin
for prophylaxis of viral, opportunistic and bacterial infections in HIV infected
children with CD4 + counts of 0.20 x 100/L or more. Journal of the American
Medical Association, 268:483-8, 1992.
Jones, D.S., Abrams, E., Ou, C.-Y., Nisherm, S., Conner, E., Davenny, K., Thomas
P., Sawyer, M., Kransinski, K., Bamji, M., Rapier, J., Kilbourne, B., Rogers,
M.: Lack of detectable human immunodeficiency virus infection in
antibody-negative children born to human immunodeficiency virus -infected
mothers. Pediatric Infectious Diseases, 12:222-7, 1993.
Mofenson, L., Bethel, J., Moye, J., Glyer, P., Nugent, R., for the National
Institute of Health and Human Development Intravenous Immunoglobulin Clinical
Trial Study Group, Bamji, M.: Effect of intravenous immunoglobulin (IVIG) on
CD4+ lymphocyte decline in HIV -infected children in a clinical trial of IVIG
infection prophylaxis. Journal of AIDS, 6:1103-14, 1993.
Morenson, L.M., Moye, J., Bethel, J., Hirschorn, R., Jordan, C., Nugent, R, for
the National Institute of Child Health and Human Development Intravenous
Immunoglobulin Clinical Trial Study Group, Bamji, M.: Effect of intravenous
immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a
clinical trial of IVIG infection prophylaxis. Journal of AIDS, 6:1103-1113,
1993.
Parekh, B.S., Shaffer, N., Couglin, R., Hung, C.H., Kransinski, K., Abrams, E.,
Bamji, M., Thomas, P., Hutson, D., Schochetman, G., Rogers, M., George, R., and
the NYC Perinatal HIV Transmission Study Group: Human immunodeficiency virus-1
specific IgA capture enzyme immunoassay for early diagnosis of human
immunodeficiency virus 1 infection in infants. Pediatrics Infectious Disease
Journal, 12:908-13, 1993.
Parekh, B.S., Shaffer, N., Couglin, R., Hung, C.H., Kransinski, K., Abrams, E.,
Bamji, M., Thomas, P., Hutson, D., Schochetman, G., Rogers, M., George, R., and
the NYC Perinatal HIV Transmission Study Group: Dynamics of maternal IgG
antibody decay and HIV-specific antibody synthesis infants born to seropositive
mothers. AIDS Research and Human Retroviruses, 9:907-12, 1993.
Parekh, B.S., Shaffer, N., Schoehetman, G., Couglin, R., Hung and the New York
City Perinatal Transmission Collaborative Study Group, Bamji, M.: HIV-1 specific
IgG capture enzyme immunoassay to study the dynamics of HIV-1 antibody and to
diagnose HIV-1 infection in infants. Annals of the New York Academy of Sciences,
693:268-271, 1993.
Brotman, R., Hutson, D., Suffet, F., Shaffer, N., Matheson, P., Suarez, M.,
Bamji, M., Kransinski, K., and the New York City Perinatal Transmission
Collaborative Study Group: Childbearing women at risk for HIV infection in New
York City. The need for family-oriented comprehensive care. AIDS and Public
Policy Journal, 8: 186-93, 1994.
Mofenson, L., Moye, J., Korelitz, J., Bethel, J., Hirschhorn, R., Nugent, R.,
and the National Institute of Child Health and Human Development Intravenous
Immunoglobulin Clinical Trial Study Group, Bamji, M.: Crossover of placebo
patients to intravenous immunoglobulin confirms efficacy for prophylaxis of
bacterial infections and reduction of hospitalizations in hum immunodeficiency
virus-infected children. Pediatric Infectious Disease Journal, 13:477-484, 1994.
Thomas, P., Weedon, J., and the New York City Perinatal Transmission
Collaborative Study Group, Bamji, M.: Seroincidence of HIV infection in women at
risk of HIV-1 infection. Journal of the American Medical Association, 272:432-3,
1994.
Thomas, P., Weedon, J., Krasinski, K., Abrams, E., Shaffer, N., Matheson, P.M.,
Bamji, M., Aditya, K., Hutson, D., Grimm, K., Beatrice, S.T., Rogers, M., and
the New York City Perinatal HIV Transmission Collaborative Study Group: Maternal
predictors of perinatal human immunodeficiency virus transmission. Pediatric
Infectious Diseases Journal, 13: 489-495, 1994.
Wang, X., Paul, M., Tetali, S., Abrams, E., Bamji, M., Gulick, L., Chirmule, N.,
Oyaizu, N., Pahwa, S.: Improved specificity of in viro anti-HIV antibody
production (IVAP; Implications for diagnosis and timing of transmission in
infants born to HIV -seropositive mothers). AIDS Research and Human
Retroviruses, 10:691-9, 1994.
Abrams, E.J., Matheson, P., Thomas, P., Thea, D., Kransinski, K., Lambert, G.,
Shaffer, N., Bamji, M., Hutson, D., Kaul, A., Bateman, D., Rogers, M., and the
New York Perinatal HIV Transmission Collaborative Study Group: Neonatal
predictors of infections status and early death among 84 HIV-1 infected infants
followed prospectively from birth. Pediatrics, 96: 451-8, 1995.
Matheson, P.B., Abrams, E.J., Thomas, P.A., Hernan, M.A., Thea, D.M., Lambert,
G., Krasinski, K., Bamji, M., Rogers, M.F., Heagarty, M., and the New York City
Perinatal HIV Transmission Collaborative Study Group: Efficacy of antenatal
zidovudine in reducing perinatal transmission of human immunodeficiency virus
type 1. Journal of Infectious Diseases, 172: 353-8, 1995.
Matheson, P.B., Weedon, J., Capelli, M., Abrams, E.J., Shaffer, N., Bamji, M.,
Krasinski, K., Lambert, G., Kaul, A., Grimm, K., Hutson, D., Thomas, P.A., and
the New York City Perinatal HIV Transmission Collaborative Study Group:
comparison of methods of estimating the mother-to-child transmission rate of
human immunodeficiency virus type 1 (HIV-1). American Journal of Epidemiology,
142:714-8, 1995.
Mofenson, L.M., Korelitz, J., Pelton, S., Moye, J., Nugent, R, Bethel, J., for
the National Institute of Child Health and Human Development Intravenous
Immunoglobulin Clinical Trial Study Group, Bamji, M.: Sinusitis in children
infected with human immunodeficiency virus: Clinical characteristics, risk
factor, and prophylaxis. Clinical Infectious Diseases, 21: 1175-81, 1995.
Bamji, M., Thea, D.M., Weedon, J., Kransinski, K., Matheson, P.B., Thomas, P.,
Lambert, G., Abrams, E.J., Steketee, R., Heagarty, M., and the New York City
Perinatal HIV Transmission Collaborative Study Group: A prospective study of
HIV-1 related disease among 512 infants born to HIV infected women in New York
City. Pediatric Infectious Diseases Journal, 15:891-898, 1996.
Paul, M.O., Tetali, S., Lesser, M.L., Abrams, E.J., Wang, X.P., Kowalski, R.,
Bamji, M., Napolitano, B., Gulick, L., Bakshi, S., Pahwa, S.: Laboratory
diagnosis of infection status in infants perinatally exposed to human
immunodeficiency virus type 1. Journal of Infectious Diseases, 173:68-76, 1996.
Thea, D.M., Lambert, G., Weedon, J., Matheson, P.B., Abrams, E.J., Bamji, M.,
Straus, W., Thomas, P.A., Krasinski, K., Heagarty, M., and the New York City
Perinatal HIV Transmission Collaborative Study Group: Benefit of primary
prophylaxis before 18 months of age in reducing the incidence of pneumocystis
carinii pneumonia and early death in a cohort of 112 human immunodeficiency
virus-infected infants. Pediatrics, 97: 59-64, 1996. |
